Polycystic Ovary Syndrome
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
At baseline, there was no detectable difference in copy number (copies/μL) of methylated (p = 0.74) or unmethylated INS cfDNA (p = 0.34) between PCOS and Control groups.
|
30953560 |
2019 |
Polycystic Ovary Syndrome
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
In conclusion, our meta-analysis suggests that the III allele of INS VNTR is associated with increased risk of PCOS.
|
25220536 |
2014 |
Polycystic Ovary Syndrome
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Lack of association of INS VNTR polymorphism with polycystic ovary syndrome: a meta-analysis.
|
24677210 |
2014 |
Polycystic Ovary Syndrome
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
The aim of our study was to analyze an association between the INS-VNTR polymorphism and PCOS in a Korean population.
|
22468791 |
2012 |
Polycystic Ovary Syndrome
|
0.400 |
GeneticVariation
|
disease |
LHGDN |
Insulin gene polymorphism in women with polycystic ovary syndrome.
|
19094425 |
2009 |
Polycystic Ovary Syndrome
|
0.400 |
Biomarker
|
disease |
BEFREE |
We have observed evidence of association with two independent TCF7L2 loci in a PCOS cohort: 1) association between the proinsulin:insulin molar ratio and the T2D locus; and 2) association with reproductive PCOS phenotype and a novel locus.
|
19351735 |
2009 |
Polycystic Ovary Syndrome
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
The results of previous research about the association of the VNTR polymorphism in 5-prime flanking region of the insulin (INS) gene with PCOS have been inconsistent.
|
19948072 |
2009 |
Polycystic Ovary Syndrome
|
0.400 |
Biomarker
|
disease |
BEFREE |
Polymorphism of C/T in the low-density lipoprotein receptor-related protein-5 gene is associated with C-peptide and proinsulin secretion but does not influence insulin sensitivity in either healthy women or women with polycystic ovary syndrome.
|
17953969 |
2008 |
Polycystic Ovary Syndrome
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
We suggest that INS VNTR genotypes are not associated with PCOS in general, but could have a certain influence on the phenotypic spectrum of the syndrome.
|
17520407 |
2007 |
Polycystic Ovary Syndrome
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
A8 was also associated with higher levels of fasting insulin and homeostasis model assessment for insulin resistance in women with PCOS and higher fasting levels of proinsulin and proinsulin/insulin ratio in brothers.
|
17785364 |
2007 |
Polycystic Ovary Syndrome
|
0.400 |
Biomarker
|
disease |
CTD_human |
The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome.
|
16123091 |
2005 |
Polycystic Ovary Syndrome
|
0.400 |
Biomarker
|
disease |
BEFREE |
To gain a robust understanding of the role of the INS-VNTR in PCOS susceptibility.
|
15705917 |
2005 |
Polycystic Ovary Syndrome
|
0.400 |
Biomarker
|
disease |
BEFREE |
However, obese n-INS and lean h-INS PCOSs showed a similar low GLUT4 expression, whereas obese h-INS PCOSs showed the lowest expression when compared with other groups.
|
15292352 |
2004 |
Polycystic Ovary Syndrome
|
0.400 |
Biomarker
|
disease |
CTD_human |
Troglitazone, an insulin-sensitizing thiazolidinedione, represses combined stimulation by LH and insulin of de novo androgen biosynthesis by thecal cells in vitro.
|
11889176 |
2002 |
Polycystic Ovary Syndrome
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
In spite of several differences in anthropometric and biochemical parameters (abdominal fat localization, increased beta-cell function, and lower insulin sensitivity in PCOS women), no effect of INS VNTR polymorphism was found on insulin secretion, insulin action, or any other screened parameter.
|
12079889 |
2002 |
Polycystic Ovary Syndrome
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
PCOS sisters had increased levels of proinsulin (P = 0.04) compared with control women, which suggested pancreatic beta-cell dysfunction in this group of sisters.
|
11994352 |
2002 |
Polycystic Ovary Syndrome
|
0.400 |
Biomarker
|
disease |
CTD_human |
Anthropometric variables and metabolism in polycystic ovarian disease.
|
2777199 |
1989 |